Blood Test

A risk model based on low-pass whole-genome sequencing of cell-free DNA predicted which patients are more likely to respond to chimeric antigen receptor T-cell therapy for large B-cell lymphoma, study results showed.

The FDA has granted breakthrough device designation to Burning Rock’s OverC multicancer blood test for early detection of esophageal, liver, lung, ovarian and pancreatic cancers, according to a company press release.

A blood-based biomarker test aided diagnosis and clinical management of Alzheimer’s disease by detecting brain amyloidosis in symptomatic patients, researchers reported at the Clinical Trials for Alzheimer’s Disease annual meeting.

A novel multicancer early detection blood test identified a common signal for more than 50 cancer types and predicted where the signal originated in the body among individuals with undiagnosed cancer.

A novel blood test that measures elevated circulating cell-free DNA may be used to evaluate disease severity and predict worse survival in patients with pulmonary arterial hypertension, according to new data published in Circulation.

Labcorp Diagnostics announced the launch of the first widely accessible blood test that provides direct evidence of neurodegeneration and neuronal injury.

French mental health diagnostics company Alcediag announced the results of a study that identified six blood biomarkers as major hallmarks of bipolar disorder.

In a recent study, Michael Olymbios, MD, the medical director of heart transplantation for Natera Inc., and colleagues found that a noninvasive blood test may help predict rejection after a heart transplant.

Heart transplant is the definitive treatment option for patients with advanced HF, yet allograft rejection and injury remain impediments to posttransplant survival despite continued advances in posttransplant outcomes.

Recent findings published in JAMA Network Open validate a blood test that uses biomarkers to determine the severity of a traumatic brain injury and whether a CT scan is warranted.